These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36535493)

  • 21. Potential of Auraptene in Improvement of Oocyte Maturation, Fertilization Rate, and Inflammation in Polycystic Ovary Syndrome Mouse Model.
    Abizadeh M; Novin MG; Amidi F; Ziaei SA; Abdollahifar MA; Nazarian H
    Reprod Sci; 2020 Sep; 27(9):1742-1751. PubMed ID: 32124396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
    Regidor PA; Schindler AE; Lesoine B; Druckman R
    Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovulation induction in polycystic ovary syndrome.
    Vause TDR; Cheung AP;
    J Obstet Gynaecol Can; 2010 May; 32(5):495-502. PubMed ID: 20500959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures.
    Huang X; Wang P; Tal R; Lv F; Li Y; Zhang X
    Int J Gynaecol Obstet; 2015 Nov; 131(2):111-6. PubMed ID: 26304048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.
    Wei W; Zhao H; Wang A; Sui M; Liang K; Deng H; Ma Y; Zhang Y; Zhang H; Guan Y
    Eur J Endocrinol; 2012 Jan; 166(1):99-105. PubMed ID: 22019891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial.
    Li Y; Ma H; Zhang Y; Kuang H; Ng EH; Hou L; Wu X
    Trials; 2013 Jul; 14():226. PubMed ID: 23866924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.
    Kuang H; Jin S; Hansen KR; Diamond MP; Coutifaris C; Casson P; Christman G; Alvero R; Huang H; Bates GW; Usadi R; Lucidi S; Baker V; Santoro N; Eisenberg E; Legro RS; Zhang H;
    Hum Reprod; 2015 Sep; 30(9):2222-33. PubMed ID: 26202922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment strategies for infertile women with polycystic ovary syndrome.
    Vitek W; Hoeger K; Legro RS
    Minerva Ginecol; 2016 Aug; 68(4):450-7. PubMed ID: 26765152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of the effects and mechanisms of berberine on a mouse model of polycystic ovary syndrome: based on intestinal flora analysis].
    Xin G; Zhang LY; Qiu HR; Wang YC; Sui YH; Xue BG; Wang HL
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):215-226. PubMed ID: 38544451
    [No Abstract]   [Full Text] [Related]  

  • 31. Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
    Ong M; Peng J; Jin X; Qu X
    Am J Chin Med; 2017; 45(3):405-422. PubMed ID: 28359195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of obesity in the development of polycystic ovary syndrome.
    Motta AB
    Curr Pharm Des; 2012; 18(17):2482-91. PubMed ID: 22376149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproductive impact of polycystic ovary syndrome.
    Usadi RS; Legro RS
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):505-11. PubMed ID: 23108198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome.
    Child TJ; Abdul-Jalil AK; Gulekli B; Tan SL
    Fertil Steril; 2001 Nov; 76(5):936-42. PubMed ID: 11704114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome.
    Zhao J; Chen Q; Xue X
    Reprod Sci; 2022 Aug; 29(8):2136-2144. PubMed ID: 34076874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate.
    Kalra SK; Ratcliffe SJ; Dokras A
    Fertil Steril; 2013 Jul; 100(1):208-13. PubMed ID: 23557762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients.
    Younis JS; Jadaon JE; Haddad S; Izhaki I; Ben-Ami M
    Fertil Steril; 2011 Apr; 95(5):1754-8. PubMed ID: 21300343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.